The dilemma of X-linked agammaglobulinemia carriers

Background: Many patients with X-linked agammaglobulinemia (XLA) nowadays have reached adulthood, as well as their sisters, possibly carriers of a deleterious Bruton tyrosine kinase variant. Studies on motherhood outcomes in families with XLA are lacking. Objective: We sought to investigate adherenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Federica Pulvirenti, MD, PhD, Cinzia Milito, MD, PhD, Francesco Cinetto, MD, PhD, Giulia Garzi, MD, Germano Sardella, MD, Giuseppe Spadaro, MD, Francesca Lippi, MD, Valentina Guarnieri, MD, Bianca Laura Cinicola, MD, Maria Carrabba, MD, PhD, Daniele Guadagnolo, MD, Giovanna Fabio, MD, Baldassarre Martire, MD, Caterina Cancrini, MD, PhD, Giulia Lanzoni, MD, Andrea Finocchi, MD, PhD, Gigliola Di Matteo, MD, PhD, Eva Pompilii, MD, Simona Ferrari, BD, PhD, Isabella Quinti, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829324001802
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555704477908992
author Federica Pulvirenti, MD, PhD
Cinzia Milito, MD, PhD
Francesco Cinetto, MD, PhD
Giulia Garzi, MD
Germano Sardella, MD
Giuseppe Spadaro, MD
Francesca Lippi, MD
Valentina Guarnieri, MD
Bianca Laura Cinicola, MD
Maria Carrabba, MD, PhD
Daniele Guadagnolo, MD
Giovanna Fabio, MD
Baldassarre Martire, MD
Caterina Cancrini, MD, PhD
Giulia Lanzoni, MD
Andrea Finocchi, MD, PhD
Gigliola Di Matteo, MD, PhD
Eva Pompilii, MD
Simona Ferrari, BD, PhD
Isabella Quinti, MD, PhD
author_facet Federica Pulvirenti, MD, PhD
Cinzia Milito, MD, PhD
Francesco Cinetto, MD, PhD
Giulia Garzi, MD
Germano Sardella, MD
Giuseppe Spadaro, MD
Francesca Lippi, MD
Valentina Guarnieri, MD
Bianca Laura Cinicola, MD
Maria Carrabba, MD, PhD
Daniele Guadagnolo, MD
Giovanna Fabio, MD
Baldassarre Martire, MD
Caterina Cancrini, MD, PhD
Giulia Lanzoni, MD
Andrea Finocchi, MD, PhD
Gigliola Di Matteo, MD, PhD
Eva Pompilii, MD
Simona Ferrari, BD, PhD
Isabella Quinti, MD, PhD
author_sort Federica Pulvirenti, MD, PhD
collection DOAJ
description Background: Many patients with X-linked agammaglobulinemia (XLA) nowadays have reached adulthood, as well as their sisters, possibly carriers of a deleterious Bruton tyrosine kinase variant. Studies on motherhood outcomes in families with XLA are lacking. Objective: We sought to investigate adherence to carrier status screening, interest in preconception and prenatal genetic counseling, and reproductive decisions in relatives with XLA. Methods: In this multicenter, retrospective cohort study, we collected a 3-generation pedigree and data on mothers and sisters of patients with XLA, including carrier status and pregnancy outcome. Results: Data on 53 adults with XLA, 52 mothers, and 33 sisters were collected. All XLA sisters received genetic counseling. Forty percent of the sisters chose to undergo carrier status determination, and 60% of them chose invasive prenatal testing. The main reasons for the sisters to decide not to undergo genetic testing were their young age and the willingness to carry on with the pregnancy regardless of the outcome of the genetic test, followed by the willingness to postpone the decision at the time of pregnancy and the decision to not have children. Prenatal testing resulted in 5 XLA diagnoses, with 2 pregnancy terminations, 1 miscarriage, and 2 XLA live births. Three carriers refused prenatal testing and had 6 live births, including 3 XLA-affected sons. One sister was diagnosed as a carrier after the birth of an XLA-affected son. In total, 9 XLA diagnoses were made, including 6 live births. Conclusions: A number of XLA sister carriers decided to carry on with their pregnancy after receiving the diagnosis of an affected fetus or after refusing prenatal testing. We propose to initiate a more extensive collaborative study to verify the effect of genetic counseling on families with XLA in other cohorts from different countries.
format Article
id doaj-art-c574108a7e0744129472bfc4287a05a6
institution Kabale University
issn 2772-8293
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Journal of Allergy and Clinical Immunology: Global
spelling doaj-art-c574108a7e0744129472bfc4287a05a62025-01-08T04:53:51ZengElsevierJournal of Allergy and Clinical Immunology: Global2772-82932025-02-0141100384The dilemma of X-linked agammaglobulinemia carriersFederica Pulvirenti, MD, PhD0Cinzia Milito, MD, PhD1Francesco Cinetto, MD, PhD2Giulia Garzi, MD3Germano Sardella, MD4Giuseppe Spadaro, MD5Francesca Lippi, MD6Valentina Guarnieri, MD7Bianca Laura Cinicola, MD8Maria Carrabba, MD, PhD9Daniele Guadagnolo, MD10Giovanna Fabio, MD11Baldassarre Martire, MD12Caterina Cancrini, MD, PhD13Giulia Lanzoni, MD14Andrea Finocchi, MD, PhD15Gigliola Di Matteo, MD, PhD16Eva Pompilii, MD17Simona Ferrari, BD, PhD18Isabella Quinti, MD, PhD19Reference Centre for Primary Immune Deficiencies, Sapienza University Hospital Policlinico Umberto I, Rome, ItalyDepartment of Molecular Medicine, Sapienza University, Rome, ItalyRare Diseases Referral Center, Internal Medicine 1, Ca’ Foncello Hospital, Treviso, Department of Medicine—DIMED, University of Padova, Padua, ItalyDepartment of Molecular Medicine, Sapienza University, Rome, ItalyDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, ItalyDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, ItalyImmunology Division, Section of Pediatrics, Meyer Children’s Hospital IRCCS, Florence, ItalyImmunology Division, Section of Pediatrics, Meyer Children’s Hospital IRCCS, Florence, ItalyDepartment of Molecular Medicine, Sapienza University, Rome, Italy; Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Rome, ItalyDepartment of Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyDepartment of Molecular Medicine, Sapienza University, Rome, ItalyDepartment of Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyPediatrics and Neonatology Unit, Maternal-Infant Department, Monsignor A. R. Dimiccoli Hospital, Barletta, ItalyResearch Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, UOC Clinical Immunology and Vaccinology IRCCS Bambino Gesù Children’s Hospital, Rome, Italy; Department of Systems Medicine University of Rome Tor Vergata, Rome, ItalyMedical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyResearch Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, UOC Clinical Immunology and Vaccinology IRCCS Bambino Gesù Children’s Hospital, Rome, Italy; Department of Systems Medicine University of Rome Tor Vergata, Rome, ItalyResearch Unit of Primary Immunodeficiencies, Academic Department of Pediatrics, UOC Clinical Immunology and Vaccinology IRCCS Bambino Gesù Children’s Hospital, Rome, Italy; Department of Systems Medicine University of Rome Tor Vergata, Rome, ItalyNext Fertility GynePro, NextClinics International, Bologna, ItalyNext Fertility GynePro, NextClinics International, Bologna, ItalyDepartment of Molecular Medicine, Sapienza University, Rome, Italy; Corresponding author: Isabella Quinti, MD, PhD, Department of Molecular Medicine, Sapienza University, Viale Regina Elena 291, Rome 00161, Italy.Background: Many patients with X-linked agammaglobulinemia (XLA) nowadays have reached adulthood, as well as their sisters, possibly carriers of a deleterious Bruton tyrosine kinase variant. Studies on motherhood outcomes in families with XLA are lacking. Objective: We sought to investigate adherence to carrier status screening, interest in preconception and prenatal genetic counseling, and reproductive decisions in relatives with XLA. Methods: In this multicenter, retrospective cohort study, we collected a 3-generation pedigree and data on mothers and sisters of patients with XLA, including carrier status and pregnancy outcome. Results: Data on 53 adults with XLA, 52 mothers, and 33 sisters were collected. All XLA sisters received genetic counseling. Forty percent of the sisters chose to undergo carrier status determination, and 60% of them chose invasive prenatal testing. The main reasons for the sisters to decide not to undergo genetic testing were their young age and the willingness to carry on with the pregnancy regardless of the outcome of the genetic test, followed by the willingness to postpone the decision at the time of pregnancy and the decision to not have children. Prenatal testing resulted in 5 XLA diagnoses, with 2 pregnancy terminations, 1 miscarriage, and 2 XLA live births. Three carriers refused prenatal testing and had 6 live births, including 3 XLA-affected sons. One sister was diagnosed as a carrier after the birth of an XLA-affected son. In total, 9 XLA diagnoses were made, including 6 live births. Conclusions: A number of XLA sister carriers decided to carry on with their pregnancy after receiving the diagnosis of an affected fetus or after refusing prenatal testing. We propose to initiate a more extensive collaborative study to verify the effect of genetic counseling on families with XLA in other cohorts from different countries.http://www.sciencedirect.com/science/article/pii/S2772829324001802XLABrutoncarriergenetic counselingprenatal testingpregnancies
spellingShingle Federica Pulvirenti, MD, PhD
Cinzia Milito, MD, PhD
Francesco Cinetto, MD, PhD
Giulia Garzi, MD
Germano Sardella, MD
Giuseppe Spadaro, MD
Francesca Lippi, MD
Valentina Guarnieri, MD
Bianca Laura Cinicola, MD
Maria Carrabba, MD, PhD
Daniele Guadagnolo, MD
Giovanna Fabio, MD
Baldassarre Martire, MD
Caterina Cancrini, MD, PhD
Giulia Lanzoni, MD
Andrea Finocchi, MD, PhD
Gigliola Di Matteo, MD, PhD
Eva Pompilii, MD
Simona Ferrari, BD, PhD
Isabella Quinti, MD, PhD
The dilemma of X-linked agammaglobulinemia carriers
Journal of Allergy and Clinical Immunology: Global
XLA
Bruton
carrier
genetic counseling
prenatal testing
pregnancies
title The dilemma of X-linked agammaglobulinemia carriers
title_full The dilemma of X-linked agammaglobulinemia carriers
title_fullStr The dilemma of X-linked agammaglobulinemia carriers
title_full_unstemmed The dilemma of X-linked agammaglobulinemia carriers
title_short The dilemma of X-linked agammaglobulinemia carriers
title_sort dilemma of x linked agammaglobulinemia carriers
topic XLA
Bruton
carrier
genetic counseling
prenatal testing
pregnancies
url http://www.sciencedirect.com/science/article/pii/S2772829324001802
work_keys_str_mv AT federicapulvirentimdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT cinziamilitomdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT francescocinettomdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT giuliagarzimd thedilemmaofxlinkedagammaglobulinemiacarriers
AT germanosardellamd thedilemmaofxlinkedagammaglobulinemiacarriers
AT giuseppespadaromd thedilemmaofxlinkedagammaglobulinemiacarriers
AT francescalippimd thedilemmaofxlinkedagammaglobulinemiacarriers
AT valentinaguarnierimd thedilemmaofxlinkedagammaglobulinemiacarriers
AT biancalauracinicolamd thedilemmaofxlinkedagammaglobulinemiacarriers
AT mariacarrabbamdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT danieleguadagnolomd thedilemmaofxlinkedagammaglobulinemiacarriers
AT giovannafabiomd thedilemmaofxlinkedagammaglobulinemiacarriers
AT baldassarremartiremd thedilemmaofxlinkedagammaglobulinemiacarriers
AT caterinacancrinimdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT giulialanzonimd thedilemmaofxlinkedagammaglobulinemiacarriers
AT andreafinocchimdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT giglioladimatteomdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT evapompiliimd thedilemmaofxlinkedagammaglobulinemiacarriers
AT simonaferraribdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT isabellaquintimdphd thedilemmaofxlinkedagammaglobulinemiacarriers
AT federicapulvirentimdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT cinziamilitomdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT francescocinettomdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT giuliagarzimd dilemmaofxlinkedagammaglobulinemiacarriers
AT germanosardellamd dilemmaofxlinkedagammaglobulinemiacarriers
AT giuseppespadaromd dilemmaofxlinkedagammaglobulinemiacarriers
AT francescalippimd dilemmaofxlinkedagammaglobulinemiacarriers
AT valentinaguarnierimd dilemmaofxlinkedagammaglobulinemiacarriers
AT biancalauracinicolamd dilemmaofxlinkedagammaglobulinemiacarriers
AT mariacarrabbamdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT danieleguadagnolomd dilemmaofxlinkedagammaglobulinemiacarriers
AT giovannafabiomd dilemmaofxlinkedagammaglobulinemiacarriers
AT baldassarremartiremd dilemmaofxlinkedagammaglobulinemiacarriers
AT caterinacancrinimdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT giulialanzonimd dilemmaofxlinkedagammaglobulinemiacarriers
AT andreafinocchimdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT giglioladimatteomdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT evapompiliimd dilemmaofxlinkedagammaglobulinemiacarriers
AT simonaferraribdphd dilemmaofxlinkedagammaglobulinemiacarriers
AT isabellaquintimdphd dilemmaofxlinkedagammaglobulinemiacarriers